share_log

Pfizer's Duchenne Pain Seen As Sarepta's Gain -- Market Talk

Pfizer's Duchenne Pain Seen As Sarepta's Gain -- Market Talk

辉瑞治疗肌肉萎缩性侧索硬化症的疼痛,可能会使赛普拉公司受益 - 市场评论
WSJ ·  2024/06/13 07:48

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发